These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 19739038)

  • 41. The metabolic syndrome: definitions, prevalence and management.
    Levesque J; Lamarche B
    J Nutrigenet Nutrigenomics; 2008; 1(3):100-8. PubMed ID: 19776619
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The emerging risk factors for cardiovascular disease: a review of the epidemiologic evidence for lipoprotein(a), homocysteine, and fibrinogen.
    Catena C; Cavarape A; Dotto L; Colussi G; Novehllo M; De Marchi S; Sechi LA
    Adv Clin Path; 2003 Jan; 7(1):3-11. PubMed ID: 19774732
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The contribution of thyroid dysfunction on cardiovascular disease in patients with chronic kidney disease.
    Tatar E; Kircelli F; Ok E
    Atherosclerosis; 2013 Mar; 227(1):26-31. PubMed ID: 23206977
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Thyroid hormones and the function of the vascular endothelium].
    Nawroth PP; Schilling T; Hamann A; Morcos M; Kasperk C
    Z Arztl Fortbild Qualitatssich; 2004 May; 98 Suppl 5():33-5. PubMed ID: 15255311
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Peptide hormones as developmental growth and differentiation factors.
    Sanders EJ; Harvey S
    Dev Dyn; 2008 Jun; 237(6):1537-52. PubMed ID: 18498096
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Emergent cardiovascular risk factors in the very elderly.
    Moura FA; Freitas WM; Sposito AC
    Expert Rev Cardiovasc Ther; 2012 Oct; 10(10):1221-5. PubMed ID: 23190062
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Hormones and erythrocytosis (author's transl)].
    Shirakura T
    Rinsho Ketsueki; 1974 Mar; 15(3):262-8. PubMed ID: 4858999
    [No Abstract]   [Full Text] [Related]  

  • 48. [Magnesium, cardiovascular risk factors and atherosclerosis].
    Fujioka Y; Yokoyama M
    Clin Calcium; 2005 Feb; 15(2):221-5. PubMed ID: 15692160
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Endocrine physiology of the infant].
    Chavarría Bonequi C; Dorantes Alvarez LM; Salgado Cabrera M
    Bol Med Hosp Infant Mex; 1982 Mar; 39(3):159-68. PubMed ID: 7093023
    [No Abstract]   [Full Text] [Related]  

  • 50. Polyvascular atherosclerotic disease: recognizing the risks and managing the syndrome.
    Yakubov S
    Curr Med Res Opin; 2009 Nov; 25(11):2631-41. PubMed ID: 19769467
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Natural antibodies against phosphorylcholine in cardiovascular disease.
    de Faire U; Frostegård J
    Ann N Y Acad Sci; 2009 Sep; 1173():292-300. PubMed ID: 19758165
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Current theories on the etiology and pathogenesis of overload diseases of bones].
    Evdokimov AE
    Vestn Khir Im I I Grek; 1991 Mar; 146(3):27-31. PubMed ID: 1654629
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Thyro-gonadic failure, a risk factor in cardiovascular pathology.
    Pitiş M; Spandonide T; Stergiopoulos C; Nicolau GY
    Endocrinologie; 1989; 27(1):43-7. PubMed ID: 2667092
    [No Abstract]   [Full Text] [Related]  

  • 54. [The role of neuroendocrine factors in the pathogenesis of cardiovascular disorders in chronic tonsillitis].
    Dutka RIa; Gnatyshak RA; Ivasiuk GM
    Vrach Delo; 1990 Jun; (6):15-6. PubMed ID: 2399708
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Value and limitations of existing scores for the assessment of cardiovascular risk: a review for clinicians.
    Cooney MT; Dudina AL; Graham IM
    J Am Coll Cardiol; 2009 Sep; 54(14):1209-27. PubMed ID: 19778661
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The impact of acute and chronic exercise on thrombosis in cardiovascular disease.
    Bacon SL; Pelletier R; Lavoie KL
    Thromb Haemost; 2009 Mar; 101(3):452-9. PubMed ID: 19277404
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Impact of current knowledge on CVD prevention.
    Roy A; Prabhakaran D
    Indian Heart J; 2008; 60(2 Suppl B):B23-8. PubMed ID: 19359760
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hormones and cardiovascular disease.
    Mendelsohn M
    Gynecol Endocrinol; 2008 Sep; 24(9):483-4. PubMed ID: 18958764
    [No Abstract]   [Full Text] [Related]  

  • 59. More than skin deep: atherosclerosis as a systemic manifestation of psoriasis.
    Alexandroff AB; Pauriah M; Camp RD; Lang CC; Struthers AD; Armstrong DJ
    Br J Dermatol; 2009 Jul; 161(1):1-7. PubMed ID: 19500102
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Hormonal influences on the blood picture].
    Bucher U; König MP
    Schweiz Med Wochenschr; 1969 May; 99(20):748-51. PubMed ID: 5785443
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.